The DOI matches its Crossref record; 185 of the 188 references it cites were found in a registry or an index.
Neuroprotective strategies involving ROS in Alzheimer disease
Open accessAbstract
Alzheimer disease (AD) is a neurodegenerative disorder in which oxidative stress is a key hallmark. It occurs early in disease pathogenesis and can exacerbate its progression. Several causes of oxidative stress have been determined over the years. First, mitochondria play an important role in the generation and accumulation of free radicals. In addition to mitochondria, inflammation can also induce oxidative damage, especially via microglia, and microglia are also important for Aβ clearance. In AD, both mitochondrial function and inflammatory response are affected, leading to increased ROS formation and oxidative damage to lipid, proteins, and nucleic acids. Some other sources have also been identified. From these findings, various neuroprotective strategies against ROS-mediated damages have been elaborated in AD research. This review recapitulates some of the major strategies used to prevent oxidative stress and disease progression. Outcomes from in vitro and in vivo studies using models of AD are encouraging. However, only a few clinical trials have provided positive results in terms of slowing down cognitive decline. Nonetheless, there is still hope for improved compounds that would better target pathways implicated in ROS production. In fact, facilitating the endogenous antioxidant system by modulating transcription has great promise for AD therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress markers increase even in the preclinical phase and during MCI, while antioxidant therapies in animal models have been shown to delay the disease course and improve cognitive functions [122, 123].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in advanced AD—characterized by widespread neuronal damage and complex pathological remodeling—the effectiveness of antioxidant therapy is significantly reduced. Numerous unsuccessful clinical trials have reported minimal cognitive improvements in patients at advanced disease stages [123–125].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Scientific evidence clearly indicates that targeting ROS and oxidative stress is more effective during the early stages of AD than in advanced stages.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In summary, ROS-targeting strategies exhibit the greatest efficacy in early AD, before irreversible neuronal damage occurs [122, 123].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.006 · Cited by 297
RetractedMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Self-citationThe Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,547
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Research works printed but not linked: 1
- 2010, Acetyl-L-carnitine, Monogr. Altern. Med. Rev., 15, 76
Cited by
Sorted by citations
Items 301–400 of 407
Ribas, G. S., Scherer, E. B. D. S., Ferreira, A. G. K., Schmitz, F., Wyse, Â. T. D. S., Rodrigues, D. G. B., Nascimento, S., García, S. C., Wajner, M., & Vargas, C. R. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.017 · Cited by 6
Li, C. (2012) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.012 · Cited by 6
Ooi, T. C., Munawar, M. A., Rosli, N. H. M., Malek, S. N. A. A., Rosli, H., Ibrahim, F. W., Azmi, N., Haron, H., Sharif, R., Shahar, S., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5126457 · Cited by 6
Acetylcholinesterase inhibitors: Modeling potential candidates
Kiametis, A. S., Martins, J. B. L., Romeiro, L. A. S., & Gargano, R. (2012) · International Journal of Quantum Chemistry · doi:10.1002/qua.24341 · Cited by 6
Artemisia annua L. extract ameliorates galactose-induced cognitive impairment in mice
Kim, M. H., Seo, J. Y., & Kim, J. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0250-5 · Cited by 6
Yang, A., Yi, X., Zhang, H., Chen, Q., Shen, R., & Kou, X. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10913-w · Cited by 5
Overview of Neurodegenerative Disorders
Sharma, S., Priya, T., Goel, N., Kashyap, D., & Garg, V. K. (2023) · Cognitive technologies · doi:10.1007/978-981-99-2154-6_1 · Cited by 5
He, M. T., Park, C. H., Shin, Y. S., Kim, J. H., & Cho, E. J. (2023) · Foods · doi:10.3390/foods12193617 · Cited by 5
Yue, Y., Ding, Y., Gao, H., Jiang, X., & Zhao, Q. (2021) · Planta Medica · doi:10.1055/a-1683-6361 · Cited by 5
Wu, C., Chen, S., Huang, W., Zhao, K., Fang, C., Liu, F., Zhang, Y., & Li, H. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126200 · Cited by 4
Reactive Oxygen Species in Neurodegenerative Disorders
Sharma, A., Tiwari, S., Sharma, H., Pathak, R., & Khan, F. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7919-6.ch012 · Cited by 4
Fern to Pharma: Potential Neuroameliorative Properties of Pteridophytes
Chandran, G., Grace, S., & Chauhan, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-04408-4_9 · Cited by 4
Investigation of the protective effect of thymoquinone of U87 cells induced by beta-amyloid
Özbolat, G., & Alizade, A. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_120 · Cited by 4
Adeyemo‐Salami, O. A., Afonja, O. J., Adeleke, O. F., Adedara, A. O., & Abolaji, A. O. (2021) · Journal of Public Health International · doi:10.14302/issn.2641-4538.jphi-21-3993 · Cited by 4
Batawi, A. H. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2082968 · Cited by 4
Assay Suitability for Natural Product Screening: Searching for Leads to Fight Alzheimerʼs Disease
Vasänge, M. (2014) · Planta Medica · doi:10.1055/s-0034-1383063 · Cited by 4
El papel de las especies reactivas de oxígeno y nitrógeno en algunas enfermedades neurodegenerativas
Hernández-Espinosa, D. R., Morín, V. B., Tena, O. B., Herrera, E. A. G., Maldonado, K. D. L., Díaz, A. S. J., Olivares, M. S., & Matuz‐Mares, D. (2019) · Revista de la Facultad de Medicina UNAM · doi:10.22201/fm.24484865e.2019.62.3.03 · Cited by 4
Kamarehei, M., Yazdanparast, R., & Aghazadeh, S. (2014) · CellBio · doi:10.4236/cellbio.2014.32008 · Cited by 4
Mukhopadhyay, C. K., Dev, S., Tapryal, N., Mukherjee, R., & Mukhopadhyay, C. (2011) · Cited by 4
Current Advances in the Studies of Oxidative Stress and Age‐Related Memory Impairment inC. elegans
Murakami, S., Cabana, K., & Anderson, D. (2011) · Wiley eBooks · doi:10.1002/9781118148143.ch25 · Cited by 4
Peng, X., Jiang, C.-C., Liu, Y.-K., Xiao, J.-R., Jiang, L., Qin, B.-B., Rim, S., Chen, X. Y., & Wang, J. (2026) · Talanta · doi:10.1016/j.talanta.2026.129391 · Cited by 3
Vanillin: a natural phenolic compound with neuroprotective benefits
Salau, V. F., & Islam, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00055-5 · Cited by 3
Mitochondrial Abnormalities in Down Syndrome: Pathogenesis, Effects and Therapeutic Approaches
Izzo, A., Mollo, N., Cicatiello, R., Genesio, R., Paladino, S., Conti, A. M. F., & Nitsch, L. (2018) · InTech eBooks · doi:10.5772/intechopen.71059 · Cited by 3
Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia
Tanwir, S. E., & Kumar, A. (2019) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2019.91001 · Cited by 3
Yang, H. S., Hwang, I. G., Choi, A., & Choe, J. (2023) · Journal of Nutrition and Health · doi:10.4163/jnh.2023.56.2.140 · Cited by 3
Polo-Cuadrado, E., Rojas-Peña, C., Acosta-Quiroga, K., Camargo-Ayala, L., Rodríguez‐Núñez, Y. A., Osorio, E. H., López, J. J., Rhonny, B.-C., & Gutiérrez, M. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100270 · Cited by 3
Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection
Gupta, R. C., & Costa, L. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00001-x · Cited by 3
Syad, A. N., & Devi, K. P. (2018) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1471563 · Cited by 3
Lipophilic Antioxidants and Cognitive Function in the Elderly
Niemchick, K., Riemersma, C., & Lasker, G. A. (2020) · Nutrition and Metabolic Insights · doi:10.1177/1178638820903300 · Cited by 3
Role of Antioxidant Nutraceuticals in Neurodegenerative Diseases
Rajadurai, M., Paramasivam, A., & Chandrashekar, L. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-8158-5_15 · Cited by 3
Inclusion of natural antioxidant compounds in fish feeds to counteract oxidative stress
López, G. E. A., Martínez, S., Hernández, M., Balois-Morales, R., Herrera, M. S., & Jiménez Ruíz, E. (2015) · Revista Bio Ciencias · doi:10.15741/revbio.03.02.01 · Cited by 3
ECSIT prevents Alzheimer’s disease pathology by regulating neuronal mitochondrial ROS and mitophagyPreprint
Lepelley, A., Vaughn, L. S., Staniszewski, A., Zhang, H., Du, F., Koppensteiner, P., Tomljanovic, Z., Carneiro, F. R. G., Teich, A. F., Ninan, I., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.09.900407 · Cited by 3
Xu, J., Yu, X., Zhang, Y., Liu, N., Guan, S., & Wang, L. (2019) · Chemical Research in Chinese Universities · doi:10.1007/s40242-019-8299-y · Cited by 2
Wang, C., Wang, Y., Xue, Q., Zhou, Z., Yan, G., & Qi, X. (2026) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2026.3655150 · Cited by 3
Suriyaamporn, P., Wongprayoon, P., Pannakkong, W., Pamornpathomkul, B., Ngawhirunpat, T., Rojanarata, T., & Opanasopit, P. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126967 · Cited by 2
The neural economics of brain aging
Kosyakovsky, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91621-5 · Cited by 3
Chauhan, P., Pandey, P., Khan, F., & Maqsood, R. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303249690231006114308 · Cited by 2
Rostagno, A. A., & Ghiso, J. A. (2025) · Antioxidants · doi:10.3390/antiox14070812 · Cited by 3
Effects of Resveratrol on Cognitive Functions
Hühn, S., & Witte, A. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805376-8.00024-1 · Cited by 3
Eskandary, A., Moazedi, A. A., Varzi, H. N., & Akhond, M. (2018) · Neurophysiology · doi:10.1007/s11062-018-9723-5 · Cited by 2
ROS and Redox Mechanism in Neurodegenerative Diseases
Zuo, L., Arballo, J., Liu, Z., & He, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11517-x · Cited by 2
Capacities for the drug correction of functional disorders in posthypoxic encephalopathy
Odinak, M. M., Emelin, А. Y., Lobzin, V. Y., & Vorobyev, S. V. (2012) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2012-390 · Cited by 2
Chandran, G., & ., M. (2016) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2016.02.49 · Cited by 2
Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria
Castellani, R. J., Correia, S. C., Moreira, P. I., & Perry, G. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00018-6 · Cited by 2
Joel, T. J., John, J. K., Gomez, L. A., & Shepherd, R. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_214 · Cited by 2
Evaluation of Antioxidant Activity of Postbiotics in Cell Cultures
Chávarri, M., & Diez-Gutiérrez, L. (2023) · Methods and protocols in food science · doi:10.1007/978-1-0716-3421-9_32 · Cited by 2
Stress oxydant et maladie d’Alzheimer
Gilbert, T., Drai, J., & Bonnefoy, M. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_10 · Cited by 2
Li, Y., Bai, H., Liu, W., Wu, T., Gu, H., Shi, G., Zhu, M. L., Zhao, N., & Huang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2850041/v1 · Cited by 2
Li, Y., Bai, H., Liu, W., Zhou, W., Gu, H., Zhao, P., Zhu, M. L., Li, Y., Yan, X., Zhao, N., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110588 · Cited by 3
Yıldız, F. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152255 · Cited by 1
Qahtan, S. A., Al‐Hussainy, A. F., Arora, V., Rekha, M. M., Kundlas, M., Chennakesavulu, K., Manu, M., Rizaev, J. A., Taher, S. G., Alwan, M., et al. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02418-4 · Cited by 1
Yadav, A., Kumar, S., Parveen, S., Kesharwani, P., & Shukla, R. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.116220 · Cited by 1
Jo, H., Shin, J., Lee, H., Bae, G., & Kim, S. (2025) · Nutrients · doi:10.3390/nu18010008 · Cited by 1
Neuroprotective Effects of Lutein: Considering Microglial Activation and Oxidative Stress
Jain, A., Srivastava, S., Kumar, S., Sahu, R., Tariq, M., & Ashraf, G. M. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_5 · Cited by 1
Baloyannis, S. J. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058709114020003 · Cited by 1
Akintunde, J. K., & Labaika, R. (2017) · PubMed Central · doi:10.6705/j.jacme.2017.0701.001 · Cited by 1
Ferulago angulata Methanolic Extract Protects PC12 Cells Against Beta-amyloid-induced Toxicity
Hashemi, L., Soodi, M., Hajimehdipoor, H., & Dashti, A. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2022.919.2 · Cited by 1
Thathapudi, J. J., John, J. K., Gomez, L. A., & Shepherd, R. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_214-1 · Cited by 1
Neuroprotective Spice Herbs for Neuroinflammation and Neurodegeneration Diseases
Ahmad, K. W. (2023) · doi:10.53902/jpssr.2023.03.000547 · Cited by 1
Bhatnagar, D., Ladhe, S., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010012 · Cited by 1
Bireche, K., Dendougui, H., Gültekin‐Özgüven, M., Hasni, S., Rahmani, Y., Abid, A., Belguidoum, M., Hadjadj, M., & Özçelik, B. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00120 · Cited by 1
Finding the missing link: Disulfide‐containing proteins via a high‐throughput proteomics approach
Khairallah, R. J., & Sadayappan, S. (2013) · PROTEOMICS · doi:10.1002/pmic.201300445 · Cited by 1
Garcı́a, N. A., Bregliani, M. M., & Pajares, A. (2017) · InTech eBooks · doi:10.5772/66478 · Cited by 1
Eskandary, A., & Moazedi, A. A. (2018) · The Journal of Qazvin University of Medical Sciences · doi:10.29252/qums.22.5.14 · Cited by 1
Coenzyme Q, mtDNA and Mitochondrial Dysfunction During Aging
Quiles, J. L., Varela‐López, A., Navarro‐Hortal, M. D., & Battino, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_10 · Cited by 1
Nikitina, O. A. (2021) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2020-5.6.14 · Cited by 1
Costantino, A. R., Charbe, N. B., Duarte, Y., Gutiérrez, M., Giordano, A., Prasher, P., Dua, K., Mandolesi, S. D., & Zacconi, F. C. M. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200142 · Cited by 1
Xiao, C., Izquierdo‐Roca, V., & Rivera-Gil, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1600967/v1 · Cited by 1
Bawa, B., & Abbott, L. C. (2012) · Open Journal of Neuroscience
MARCADORES MITOCONDRIALES DE ESTRÉS OXIDATIVO Y LIPOTOXICIDAD EN DORADA (Sparus aurata)
Bermejo-Nogales, A. (2012) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/15189
Multiplexing Techniques in Quantitative Proteomics to Study Disease
Evans, A. R. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Síntese de um potencial inibidor da B-secretase e sua interação com o enzima
Pereira, R. A. G. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
de Carvalho, A. T., Serra, N., & de Carvalho, M. M. (2014)
da Silva, C. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-09062015-144939
Salt marsh plants as source of bioactive compounds
Rocha, M. I. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ramos, R. J. R. S. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Mitochondrial Antioxidants in Neuroprotection
Fiskum, G. M., & Laird, M. D. (2012) · Oxidative stress and disease · doi:10.1201/b12308-26
The role of angiopoietin-like 4 in inflammation
Phua, T. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72319
Brain Uptake and Metabolism of Eicosapentaenoic Acid in Rodents
Chen, T.-H. C. (2014) · TSpace (University of Toronto)
MaCheng-cheng, W.-W., Zhou, H., YuYuan-di, H.-L., Ding, X., & Xiao, X. (2013)
Zhou, X., Meng-Bei, X., Ting-Yu, J., Rong, P.-Q., Guo-Qing, Z., & Yan, L. (2018) · Aging and Disease · doi:10.14336/ad.2018.015
Oladele, J. O., Oladele, O. T., Adewole, T. S., Oyeleke, O. M., & Oladiji, A. T. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5129-8.ch010 · Cited by 1
Mohammadi, R., Bolboli, L., Pourvaghar, M. J., & Afroundeh, R. (2023) · Studies in Medical Sciences · doi:10.52547/umj.34.1.1
Mohammadi, R., Bolboli, L., Pourvaghar, M., & Afroundeh, R. (2023) · یافته · doi:10.32592/yafteh.2023.24.4.5
Zahid, S., Khawaja, A. I., Chinnam, S., Ahmad, Z., Riaz, H., Yallur, B. C., Malik, A., Hassan, K. D., Khalid, B., Qaddoos, A., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4358501/v1
Exploration of The Therapeutic Effects of a Dietary Flavonoid Rutin
Kundu, S., Jhulki, S., & Pal, A. (2024) · doi:10.52756/lbsopf.2024.e01.014
Chiang, C.-I., Liu, C., Hao, P.-J., Chu, C., Chu, C.-Y., Liu, C., Hu, C., Lee, Y.-L. A., Hu, C., Liu, Y., et al. (2025) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2025.106507
Yin, C., Nelen, I., Harms, A. C., Hartman, R. D., Bos, S., Kooij, C. N.-V., Hankemeier, T., Kindt, A. S. D., & de Lange, E. C. M. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00811-8
Nutraceutical Antioxidants and Their Therapeutic Potential in Neurodegeneration
Ross, E. K. (2012) · Digital Commons - DU (University of Denver)
Xu, C., Mei, Y., Yang, R., Luo, Q., Zhang, J., Kou, X., Hu, J., Wang, Y., Li, Y., Chen, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25708927
Photo-Secondary Metabolites as a Potential Therapeutic Gateway for Alzheimer’s Disease Management
Kathiresan, D. S., Puthamohan, V. M., Ganesan, S., & Arun Nagendran., N. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_10
Complementary and Alternative Medicine Therapy to Inhibit ROS-Mediated Inflammatory Disorders
Rehman, A., Loh, T. C., Chia, S. L., & Foo, H. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_23 · Cited by 1
Anwer, R., Ullah, I., Khan, A., Mir, M. A., Bashir, N., Shah, S. U. A., & Ayaz, M. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02177-7
Mitochondria, neurosteroids and biological rhythms : implications in health and disease states
Grimm, A. (2015) · theses.fr (ABES) · doi:10.70675/8aac5aa9z77cdz49bdz9cf5z0ff0b5dd0f84
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Rakotoarisoa, M. (2021) · theses.fr (ABES) · doi:10.70675/7bf6365czfebbz4b3az9400z0a82f6d9364f
Ryu, D. H., Cho, J. Y., Jung, J. W., Ho, H.-T., Kim, H. M., Park, N.-Y., Ahn, N.-H., Lee, J.-H., Park, J.-S., Lee, D.-S., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c00935
Sun, S., Zuo, Y., & Yan, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177408
Metadata
- Authors
- Dumont, M., & Beal, M. F.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Dumont, Magali
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 51
- Issue
- 5
- Pages
- 1014-1026
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3070183
- OpenAlex
- W2080084871
- Cited by
- 402
- References
- 188
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 21 · 2023: 20 · 2022: 21 · 2021: 22 · 2020: 26 · 2019: 28 · 2018: 19 · 2017: 36 · 2016: 28 · 2015: 29 · 2014: 36 · 2013: 34 · 2012: 34
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG20729, R01AG020729, P01AG014930, P01-AG14930)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- Alzheimer's disease, reactive oxygen species, oxidative stress, neuroprotection, mitochondria, microglia, neuroinflammation, amyloid-beta clearance, antioxidant defense, transcriptional regulation, neurodegeneration, cognitive decline
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Clinical Trials as Topic, Disease Models, Animal, Humans, Inflammation, Mitochondria, Oxidation-Reduction, Reactive Oxygen Species, Microglia, Oxidative Stress, Disease Progression, Neuroprotective Agents, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review